RT Bybit Alpha (@BybitAlpha)📣 Introducing Bybit Megadrop, your new go-to for early token access🔐 Lock $MNT or $USDT to earn from a pool of 20,000,000 $COA.Start farming airdrops the smart way!Check the Megadrop: https://t.co/9tRLazxoph#CryptoArk #BybitListing https://t.co/CgdxmgszuY ...

Core Viewpoint - OptimizeRx Corp. is set to discuss its second quarter financial results for the period ending June 30, 2025, during a conference call scheduled for August 7, 2025 [1][2]. Company Overview - OptimizeRx is a leading healthcare technology company that focuses on connecting life science brands with patients and healthcare providers through innovative solutions [4]. - The company utilizes AI-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to enhance engagement and improve patient outcomes [4]. - OptimizeRx is committed to privacy-safe, patient-centric technology, ensuring impactful interactions that deliver therapies to the right patients at the right time [5]. Conference Call Details - The conference call will take place on August 7, 2025, at 4:30 p.m. Eastern Time, with a question-and-answer session following the management's presentation [2]. - Participants can join the call via toll-free and international numbers, and a webcast will also be available [2]. - A replay of the call will be accessible for 12 months on the company's investor relations website [3].

RT Kraken Pro (@krakenpro)MNT NEW PERPETUAL$MNT @0xMantle perpetual futures now live with up to 20x leverage 🔥Why choose Kraken Pro futures:☑️ 40+ collateral options☑️ 360+ marketsOpen MNT perp:https://t.co/IJwDjSblx8*Geo restrictions apply https://t.co/DIvdZZz0NL ...

芯片超人现有 1600平米 芯片智能仓储基地，现货库存型号 1000+ ，品牌高达 100种 ， 5000万颗 现 货库存芯片，总重量 10吨 ，库存价值高达 1亿+ 。同时，芯片超人在深圳设有独立实验室，每颗物料 均 安排QC质检 。 求购以下料号 | 品牌 | 型号 | 数量 | | --- | --- | --- | | mini | GVA-62+ | 5000 | | ST | STM32H743VIT6 | 5000 | | ADI | AD5453YRMZ | 15K | 优势物料，特价出售 | 品牌 | 型号 | 数量 | 年份 | | --- | --- | --- | --- | | ADI | ADRF5545ABCPZN-R7 | 30K | 22+ | | TI | TMS320F28027PTT | 7499pcs | 23+ | | WINBOND | W83627DHG | 876pcs | 21+ | | ST | STTH30R06CW | 10K | 20+ | | ST | L9950TR | 4800pcs | 21+ | | Infineon | TLI4971-A ...

Group 1 - The company "Chip Superman" has a 1,600 square meter intelligent warehouse for chips, with over 1,000 stock models and around 100 brands, totaling 50 million chips in stock valued at over 100 million [1] - The company operates an independent laboratory in Shenzhen, ensuring quality control (QC) for each material [1] - The company has served a total of 19,800 users and can complete transactions in as fast as half a day [4] Group 2 - The company is currently seeking to purchase specific chip models, including 300,000 units of LTST-C193KFKT-5A and 5,000 units of STM32H743VIT6 [2] - The company is offering discounted sales on advantageous materials, including 2,000 units of ADM2483BRWZ and 30,000 units of ADRF5545ABCPZN-R7, with various years of production [3] Group 3 - The company promotes its "Factory Surplus" mini-program for users who are unable to find or sell chips at better prices [5] - The company also provides a web version for users to access its services [6]

Core Viewpoint - TCL Technology has successfully completed a significant acquisition, enhancing its position in the display business by acquiring a 21.5311% stake in Shenzhen Huaxing Semiconductor, bringing its total ownership to 84.2105% [1][4][5] Group 1: Acquisition Details - The acquisition of Shenzhen Huaxing Semiconductor was valued at 115.62 billion yuan, with 72.03 billion yuan paid in cash and 43.59 billion yuan through the issuance of new shares [4] - The company will issue approximately 986 million new shares, which are set to be listed on July 10 [4] - Following the transaction, Shenzhen Major Industry Development Fund will become a major shareholder with a 4.99% stake, while the chairman's shareholding will be diluted from 6.74% to 6.40% [4] Group 2: Strategic Focus - TCL Technology is focusing on three core business areas: semiconductor display, new energy photovoltaic, and semiconductor materials, with the semiconductor display business becoming a primary revenue source [1][5] - The company aims to strengthen its core competitiveness in the semiconductor display industry through this acquisition, reinforcing its leading position [5] Group 3: Financial Performance - In the first quarter of 2025, TCL Technology reported a net profit attributable to shareholders of 9.58 billion yuan, marking a year-on-year increase of 1254.24% [2][11] - The company achieved a revenue of 401.19 billion yuan in the first quarter of 2025, a slight increase of 0.43% year-on-year [11] Group 4: Market Position - TCL Technology has established itself as a leader in the global display market, particularly in large-size panels, holding the number one market share for TV panels over 98 inches [9][11] - The company has invested over 260 billion yuan in its semiconductor display business, establishing a strong global presence with multiple high-generation panel lines and module factories [10]

Core Insights - OptimizeRx Corp. has appointed Steve Silvestro, the current CEO, to its Board of Directors effective June 20, 2025, enhancing leadership and execution of value creation plans [1][2][3] Company Leadership - Steve Silvestro joined OptimizeRx in 2019, became CEO in March 2025, and previously served as interim CEO from January 2025 [2][4] - The Board of Directors has recognized Silvestro's leadership and the progress made under his tenure, which has strengthened the company's position and laid a foundation for long-term shareholder value [3] Strategic Direction - Silvestro expressed optimism about OptimizeRx's direction, emphasizing a focus on operational excellence, customer satisfaction, and a strong outlook for 2025 and beyond [3] - The company aims to deepen its value proposition with pharmaceutical partners, accelerate the shift towards a recurring revenue model, and progress towards achieving Rule of 40 performance [3][4] Company Overview - OptimizeRx is a healthcare technology company that connects life science brands with patients and healthcare providers through innovative AI-driven tools [5][6] - The company is committed to privacy-safe, patient-centric technology, partnering with leading pharmaceutical and life sciences companies to transform healthcare [6]

此外， 越南离中国大陆的距离近，原材料运输成本低，再加上越南可以本地化生产部分生产模组 所需的原材料，因此越南自然成为了面板厂海外布局模组产能的重要选择。 那 么， 面板厂 目前 在越南规划模组产能的进度如何？ 外界经营环境复杂多变，为分散供应链风险，美 系 IT品牌，如Dell、HP等，均要求面板厂在中国 大陆以外的地区生产模组。 鉴于 美 系 IT品牌的市场地位举足轻重，面板厂为应对其需求，纷纷 在越南规划模组产能。 NB模组方面，友达 、京东方和LG Display等多个NB面板厂均在越南规划NB模组产能。 友达 和 龙腾光电（ IVO ） 的NB模组产能已经达到可量产状态，其他的模组产能在今年下半年也会陆续 达到可量产状态。 MNT模组方面，友达（ AUO ） 、LG Display、BOE 京东方 和 TCL华星（ CSOT ） 已经在越 南规划MNT模组产能。AUO和LGD的模组产能目前已经达到可量产 （ MP ） 状态， 京东方 和 TCL华星 的模组产能在今年下半年也会陆续达到可量产状态。 扩产方式上， 友达 、 京东方 和 TCL华星 采取自建的方式获取模组产能，而LGD则是通过与第 三方合 ...

公司如何看待 LCD行业供需情况？行业面板厂商坚持"按需生产"的经营策略，需求端库存实现加速去化，产业库存趋近健康标准，行业需求归正 常节奏。中国大陆将成为确定性市场，能够以较高的确定性对冲国际贸易环境变化的不确定性。 公司如何看待 LCD产品价格趋势？根据咨询机构数据及分析，得益于良好的终端需求，LCD TV主流尺寸面板价格自2025年1月起全面上涨并延续 至3月；进入二季度，LCD TV 面板采购需求预计逐步降温，5月LCD TV 产品价格维持稳定。LCD IT方面，MNT 面板价格保持温和上涨态势， NB面板价格整体维持稳定。 柔性 AMOLED业务进展？公司在柔性 MOLED 领域多年布局，已经构建起产能规模和技术优势，并积累了较好的客户资源，在柔性MOLED领域 全面覆盖手机主要 Top品牌客户，同时积极布局车载、IT等中尺寸创新应用，匹配下游客户需求。未来，公司将持续强化自身的产品和技术能 力，稳步提升柔性 MOLED业务整体竞争力。 公司投建的第 6代 AMOLED生产线项目进度？5月20日，公司成都第8.6代MOLED生产线项目提前4个月开始工艺设备搬入，标志着该产线由建设 阶段开始向产线运营 ...

据了解，京东方A就投资者提问进行了回应。在LCD行业供需方面，厂商坚持"按需生产"，库存加速去 化，行业格局重塑，未来中国大陆市场确定性高；LCD行业平均稼动率自 2024 年 11 月回升，2025年一 季度保持在80%以上，二季度将灵活调整；LCD产品价格方面，TV主流尺寸面板价格2025年1月至3月 上涨，二季度采购需求或降温，IT方面MNT面板温和上涨，NB面板整体稳定。 据了解，该公司成都第8.6代AMO LED 生产线项目于5月20日提前4个月工艺设备搬入，向运营阶段转 换；2024年折旧约380亿，随着新项目转固和成熟产线折旧到期，折旧预计今年达峰值，公司将优化产 线定位提升盈利。 据了解，目前LCD生产线进入成熟期，公司未来资本支出围绕"屏之物联"战略，聚焦 半导体 显示主 业，在 物联网 创新等四个高潜航道布局，具体方向涉及新项目、已建项目尾款和现有产线维护等。 调研详情如下： 2025年5月22日， 京东方A 披露接待调研公告，公司于5月21日接待 中信建投 、平安资产、国寿资产、 中再资产、华夏久盈资产等6家机构调研。 公告显示，京东方A参与本次接待的人员共2人，为证券事务代表罗文捷，董 ...